New Blood Test May Predict Organ Aging and Future Disease Risk

Researchers at Stanford Medicine have developed a groundbreaking blood test that can estimate the biological age of major organs, providing early insight into disease risk and longevity. Unlike chronological age, biological age reflects how well different organs are functioning, revealing that the body does not age uniformly.

The study analyzed blood samples from 44,498 adults aged 40–70 enrolled in the UK Biobank. By measuring nearly 3,000 proteins associated with specific organs, researchers created biological aging profiles for 11 major organ systems, including the brain, heart, lungs, kidneys, liver, and immune system.

The findings showed that approximately one-third of participants had at least one organ aging significantly faster or slower than expected, while nearly one in four had multiple organs with accelerated or delayed aging. These differences were strongly associated with future disease risk.

Among all organs, the brain emerged as the strongest predictor of longevity. Individuals with biologically older brains had a substantially higher risk of mortality and were more than three times as likely to develop Alzheimer's disease. Conversely, those with younger brain profiles demonstrated a significantly lower risk of death and neurodegenerative disease.

The study also found that the biological age of individual organs accurately predicted organ-specific diseases years before symptoms appeared. For example, accelerated heart aging was linked to cardiovascular disease, older lungs predicted chronic respiratory conditions, and biologically older kidneys were associated with an increased risk of kidney failure.

In a related investigation, researchers extended the analysis to individual cell types within organs. They discovered that cellular aging also varies considerably, with older astrocytes in the brain linked to a higher risk of Alzheimer's disease and aged muscle cells associated with an increased likelihood of developing amyotrophic lateral sclerosis (ALS).

These findings highlight the potential of organ-age testing to shift healthcare from reactive treatment to proactive prevention. By identifying accelerated aging before disease develops, clinicians may be able to implement earlier interventions, monitor treatment effectiveness, and personalize preventive strategies based on an individual's unique biological aging profile.

Although the technology remains in the research phase, investigators hope to refine the test and make it more widely accessible in the coming years. If validated in broader populations, this approach could transform preventive medicine by enabling earlier detection of age-related diseases and supporting more personalized healthcare.

The research reinforces a growing understanding that aging is not a single process affecting the entire body equally. Instead, each organ follows its own biological aging trajectory, offering valuable insights into future health, disease susceptibility, and lifespan.

Source: https://www.thebrighterside.news/post/new-blood-test-finds-different-body-parts-age-at-different-speeds/